2022 Saudi guidelines for the management of dyslipidemia

Jamilah AlRahimi¹, Shukri AlSaif², Mirvat Alasnag³, Zuhier Awan⁴, Fawaz Almutairi⁵, Hajer Al Mudaiheem⁶, Baris Gencer⁷, Alberico L Catapano⁸, François Mach⁹, Adel Tash^10
1 Department of Cardiology, King Faisal Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Dammam, Saudi Arabia
² Department of Cardiology, Saud AlBabtain Cardiac Center, Dammam, Saudi Arabia
³ Department of Cardiology, Catheterization Laboratory, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
⁴ Medicine, Biochemistry and Molecular Genetics, Clinical Biochemistry Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
⁵ Department of Cardiology, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
⁶ Therapeutic Affairs Department, Ministry of Health, Riyadh, Saudi Arabia
⁷ Department of Cardiology, Geneva University Hospital, Geneva; Institute of Primary Healthcare (BIHAM), Bern University, Bern, Switzerland
⁸ Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
⁹ Department of Cardiology, Geneva University Hospital, Geneva, Switzerland
¹⁰ Cardiac Services Development, Ministry of Health; National Heart Center, Saudi Health Council, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Jamilah AlRahimi
King Abdullah International Medical Research Center, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 9515, Jeddah 21423
Saudi Arabia

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/heartviews.heartviews_102_22